Catherine M. Clavel

Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity

Zenita Adhireksan, Gabriela E. Davey, Pablo Campomanes et al. · Nature Communications · 2014 · 295 citations · Full text

Antiproliferative activity of chelating N,O- and N,N-ruthenium(ii) arene functionalised poly(propyleneimine) dendrimer scaffolds

Preshendren Govender, Anna K. Renfrew, Catherine M. Clavel et al. · Dalton Transactions · 2010 · 152 citations · Full text

Engineering, Maldi-tof Mass Spectrometry, Organic Chemistry +18

Naphthalimide-Tagged Ruthenium–Arene Anticancer Complexes: Combining Coordination with Intercalation

K.J. Kilpin, Catherine M. Clavel, Fabio Edafe et al. · Organometallics · 2012 · 152 citations · Full text

Inorganic Chemistry, Medicinal Chemistry, Engineering +12

Modulating the Anticancer Activity of Ruthenium(II)–Arene Complexes

Catherine M. Clavel, Emilia Păunescu, Patrycja Nowak‐Sliwinska et al. · Journal of Medicinal Chemistry · 2015 · 114 citations · Full text

Inorganic Chemistry, Medicinal Chemistry, Other Ligands +15

Exploring the Versatility of Cycloplatinated Thiosemicarbazones as Antitumor and Antiparasitic Agents

Prinessa Chellan, Kirkwood M. Land, Ajit Shokar et al. · Organometallics · 2012 · 90 citations · Full text